16 OUTCOMES IN PATIENTS WITH ADVANCED MYELODYSPLASTIC SYNDROME RECEIVING EX-VIVO T-CELL DEPLETED OR UNMODIFIED ALLOGRAFTS: COMPARISON OF RESULTS AT TWO INSTITUTIONS.

Authors :: Tamari, R.
Oran, B.
Hilden, P.
Papadopoulos, E.
Kongtim, P.
Rondon, G.
Jakubowski, A.
Anderssson, B.
Devlin, S.
Ahmed, S.
Young, J.
Popat, U.
Chen, J.
De Lima, M.
O'Reilly, R.
Giralt, S.
Champlin, R.
Castro-Malaspina, H.
Source :: Leukemia Research. Apr2015 Supplement 1, Vol. 39, pS6-S7. 1p.
Publication Year :: 2015

Subjects :: *MYELODYSPLASTIC syndromes
*5Q deletion syndrome
*PRELEUKEMIA
*LEUKEMIA
*LEUKEMIA treatment
*LEUKEMIA diagnosis
*MEDICAL care

Full Text Access

Tools